iSpecimen

ISPCNasdaq United States Health Care Biotechnology: Commercial Physical & Biological Resarch

Market cap

$3.148 M

$1.25 -5.30%

Close of 22 Sept 2026

Revenue

$1.93M

#3424 by revenue

Earnings

-$10.5M

Loss-making

Shares outstanding

2,518,590

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Commercial Physical & Biological Resarch, ranked by market cap

All 12 →

#8Nrc HealthNRC$483.5M
#9MaxcyteMXCT$128.0M
#10OneMedNetONMD$38.5M
#11bioAffinity TechnologiesBIAF$9.98M
#12iSpecimenISPC$3.15M

What if iSpecimen were worth as much as…

Open the what-if tool →

Gold $30.2T

$12,004,322

Per share 9,603,457× higher

Bitcoin $1.74T

$691,519.77

Per share 553,216× higher

Nvidia $5.52T

$2,190,021

Per share 1,752,017× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for iSpecimen are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.